Ben Tre Pharmaceutical JSC

Ben Tre Pharmaceutical JSC ROCE

The Return on Capital Employed (ROCE) of Ben Tre Pharmaceutical JSC (DBT.VN) as of Nov 13, 2026 is 18.56 %. In the previous year, Return on Capital Employed (ROCE) was 27.93 % — a change of -33.57% (lower).

ROCE

18.56 %

YoY

-33.57%

Last updated:

In 2024, Ben Tre Pharmaceutical JSC's return on capital employed (ROCE) was 18.56 %, a -33.57% increase from the 27.93 % ROCE in the previous year.

The Ben Tre Pharmaceutical JSC ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2014
12.66 VND
Jan 1, 2015
3.29 VND
Jan 1, 2020
16.14 VND
Jan 1, 2021
5.74 VND
Jan 1, 2022
16.61 VND
Jan 1, 2023
27.93 VND
Jan 1, 2024
18.56 VND
The Ben Tre Pharmaceutical JSC ROCE history
YEARROCEYoY
18.56 %-33.57%
27.93 %+68.16%
16.61 %+189.52%
5.74 %-64.46%
16.14 %+390.11%
3.29 %-73.99%
12.66 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Ben Tre Pharmaceutical JSC Stock analysis

What does Ben Tre Pharmaceutical JSC do? Ben Tre Pharmaceutical JSC manufactures and distributes pharmaceutical products, including medicinal products through its subsidiaries. The company wholesales, imports, and exports pharmaceuticals, materials, chemicals, packagings, and biological products. It also retails drugs and trades supplements, medical equipment, supplies, and machinery. The firm rents commercial space for additional revenue. Its primary customers are healthcare providers, pharmacies, and medical institutions requiring pharmaceuticals and medical supplies. The company's revenue streams include pharmaceutical manufacturing, wholesale distribution, import/export services, retail drug sales, and commercial space rentals. Key segments are pharmaceuticals, medical equipment, and biological products. The firm serves healthcare sectors through its subsidiaries and direct retail channels. Revenue is generated from both domestic and international trade activities. Ben Tre Pharmaceutical JSC's products include pharmaceuticals, medicinal products, medical equipment, and supplements. The company's brands are not specified in the business description. It targets healthcare providers, pharmacies, and medical institutions as its main buyers. The firm's operations span manufacturing, distribution, retail, and commercial leasing within the pharmaceutical and medical sectors. Ben Tre Pharmaceutical JSC is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Ben Tre Pharmaceutical JSC's Return on Capital Employed (ROCE)

Ben Tre Pharmaceutical JSC's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Ben Tre Pharmaceutical JSC's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Ben Tre Pharmaceutical JSC's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Ben Tre Pharmaceutical JSC’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Ben Tre Pharmaceutical JSC stock

Return on Capital Employed (ROCE) of Ben Tre Pharmaceutical JSC is 18.56 % in 2024.

Return on Capital Employed (ROCE) of Ben Tre Pharmaceutical JSC changed from 27.93 % to 18.56 %, representing a -33.57% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Ben Tre Pharmaceutical JSC since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Ben Tre Pharmaceutical JSC with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Ben Tre Pharmaceutical JSC

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Ben Tre Pharmaceutical JSC